Navigation Links
Varian, Inc. Acquires Analogix Business
Date:11/5/2007

PAULO ALTO, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Varian, Inc. (Nasdaq: VARI) today announced that it has acquired the assets of Analogix, Inc., a privately owned company based in Burlington, Wisconsin, for approximately $11 million in cash plus assumed net debt, subject to certain net asset adjustments. The transaction also includes the opportunity for additional purchase price payments over three years, depending on future milestones and financial performance. Those future payments could total up to $4 million if performance targets are achieved.

Analogix is a technology leader in the development of consumables and instrumentation for automated compound purification, using flash chromatography, for the pharmaceutical industry.

"The acquisition of Analogix is strategic to the advancement of Varian's goal to grow applications based consumables products and to further broaden its product offering to the pharmaceutical industry," said Garry Rogerson, President and CEO, Varian, Inc. "Analogix has demonstrated an ability to successfully meet customer needs in the area of drug discovery and to grow its business rapidly in North America. Analogix products will now be distributed more effectively on a global basis via Varian's worldwide distribution network."

"The sale of Analogix to Varian is a win-win situation," said Nick DeMarco, President of Analogix. "With a dedicated group of employees, we have been able to bring the company to its current level of success. I am excited for both our employees and our customers to be able to take Analogix to the next level of development and distribution as part of Varian."

Flash chromatography is a technique used by medicinal chemists in the pharmaceutical industry to purify novel synthetic compounds quickly. The Analogix business produces consumables (pre-packed columns) and automated instrumentation to increase throughput in the critical purification step for organic compounds and peptides.

This acquisition is part of Varian, Inc.'s strategy to strengthen the company's product portfolio, especially in the area of laboratory consumables, with internal research and development and strategic acquisition of complimentary products and technologies.

About Varian, Inc.

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum components, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,900 people and operates manufacturing facilities in 13 locations in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2007 sales of $921 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site: http://www.varianinc.com.

For More Information, Contact:

Investor Relations

Varian, Inc.

650.424.5471

ir@varianinc.com


'/>"/>
SOURCE Varian, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
2. Varian, Inc. Offers New Products for the Rapid Purification of Synthetic Oligonucleotides.
3. Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia
4. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
5. Food Bank For New York City Acquires FoodChange
6. Concentra Acquires Assets of Renew Health & Wellness
7. DaVita Acquires Majority Stake in HomeChoice Partners, Inc.
8. NNN Healthcare/Office REIT Acquires St. Mary Physicians Center in Long Beach, California
9. NNN Healthcare/Office REIT Acquires 2750 Monroe Boulevard in Valley Forge, Pennsylvania
10. Hologic Acquires Biolucent, Inc.
11. Radiation Therapy Services Acquires North Carolina Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... ... 06, 2016 , ... Research has shown that building shame ... frequency and level of relapse. , At the 2016 iaedp Symposium, ... explore the critical tasks of the recovery phase and beyond including relapse prevention ...
(Date:2/5/2016)... ... February 05, 2016 , ... Today, the Whole-Food Warrior ... that the much-anticipated feature with author Jahnavi Foster, specialist in healthy vegetarian cuisine, will ... , Each week, on his weekly Whole-Food Warrior TV show, Frank Davis highlights Whole-Food ...
(Date:2/5/2016)... Santa Rosa, CA (PRWEB) , ... February 05, ... ... are pleased to announce the addition of micro-needling services in their Napa Valley ... appearance. The founders of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... once again host, Swirl, A Wine Tasting Event at the La Gorce Country ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Regular gym users ... themselves having to wait longer to access the treadmills. It’s a predictable trend. After ... to lose weight and get in shape by joining gyms, starting new walking or ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... Summary Global Markets Direct,s, ,Wegener Polyangiitis - ... the Wegener Polyangiitis,s therapeutic pipeline. This report ... Wegener Polyangiitis, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
(Date:2/4/2016)... Feb. 4, 2016 Summary Breast cancer, ... and the most common cancer in women worldwide, accounting ... exceedingly prevalent. The number of women diagnosed with breast ... the number of deaths has declined due to earlier ... has been revolutionized in the past four decades, especially ...
(Date:2/4/2016)... Frontier Pharma: Chronic Obstructive Pulmonary Disease ... Chronic Obstructive Pulmonary Disease (COPD) is ... the airways and lungs. Persistent breathing difficulties and ... one of the leading causes of morbidity and ... COPD is linked to cumulative exposure to risk ...
Breaking Medicine Technology: